Share on LinkedInShare on LinkedIn

ARTICLE · 13 MAY 2026

FDA Signals Increased Cosmetics Oversight Through MoCRA Implementation And Other Regulatory Efforts

Kelley Drye & Warren LLP
Kelley Drye & Warren LLP
Contributor
Kelley Drye & Warren LLP

Kelley Drye & Warren LLP

About Kelley Drye We’re focused—in key areas of the law and on the nuances of each matter—to help...

View firm profile
Explore more from Kelley Drye & Warren LLP

Last week, FDA touted its achievements in connection with implementing the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) – noting that the agency had ​“worked tirelessly, mostly using...

United StatesMedia, Telecoms, IT, Entertainment

Last week, FDA touted its achievements in connection with implementing the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) – noting that the agency had “worked tirelessly, mostly using existing resources, to implement the provisions added or required by MoCRA.” Enacted on December 29, 2022, MoCRA marks the most significant reform of U.S. cosmetic regulation in over 80 years and significantly expands FDA’s authority and imposes substantial new obligations on cosmetic manufacturers, processors, and brand owners. Key changes include:

  • Mandatory facility registration and product listing, including ingredient disclosure;

  • Serious adverse event reporting requirements;

  • Recordkeeping obligations to substantiate product safety;

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from